NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 8 filers reported holding NOVELION THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $168,000 | -7.2% | 232 | 0.0% | 0.00% | – |
| Q2 2019 | $181,000 | -24.9% | 232 | +18.4% | 0.00% | – |
| Q1 2019 | $241,000 | +46.1% | 196 | 0.0% | 0.00% | – |
| Q4 2018 | $165,000 | -71.6% | 196 | 0.0% | 0.00% | – |
| Q3 2018 | $580,000 | -19.6% | 196 | 0.0% | 0.00% | – |
| Q2 2018 | $721,000 | -93.6% | 196 | -93.9% | 0.00% | – |
| Q1 2018 | $11,252,000 | -18.5% | 3,215 | -27.3% | 0.00% | – |
| Q4 2017 | $13,800,000 | +33.0% | 4,423 | +199.7% | 0.00% | – |
| Q3 2017 | $10,376,000 | -29.1% | 1,476 | -6.9% | 0.00% | – |
| Q2 2017 | $14,630,000 | – | 1,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|